0001813229-20-000002.txt : 20200527 0001813229-20-000002.hdr.sgml : 20200527 20200526201153 ACCESSION NUMBER: 0001813229-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200526 EFFECTIVENESS DATE: 20200527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BCD Bioscience, Inc. CENTRAL INDEX KEY: 0001813229 IRS NUMBER: 832990500 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367717 FILM NUMBER: 20912456 BUSINESS ADDRESS: STREET 1: 231 G STREET STREET 2: SUITE 24 CITY: DAVIS STATE: CA ZIP: 95616 BUSINESS PHONE: (530) 400-8155 MAIL ADDRESS: STREET 1: 231 G STREET STREET 2: SUITE 24 CITY: DAVIS STATE: CA ZIP: 95616 D 1 primary_doc.xml X0708 D LIVE 0001813229 BCD Bioscience, Inc. 231 G STREET SUITE 24 DAVIS CA CALIFORNIA 95616 (530) 400-8155 DELAWARE Calyxo Biosystems, Inc. None Corporation true 2019 Steven Watkins 231 G Street Suite 24 Davis CA CALIFORNIA 95616 Executive Officer Director Promoter Carlito Lebrilla 231 G Street Suite 24 Davis CA CALIFORNIA 95616 Director Promoter Biotechnology Decline to Disclose 06b false 2020-05-13 false true false 0 4840000 4490000 350000 false 14 0 0 0 false BCD Bioscience, Inc. Steven Watkins Steven Watkins CEO 2020-05-24